Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Phase 2 clinical data shows a clean linear dose-response relationship, with each dose tier producing approximately 3 additional percentage points of weight loss
Full responsibility for the safe storage, handling, and application of the product rests with the purchaser
Yes, but combinations should be managed by a qualified provider to ensure safety and synergy
15% des AR* en zinc, slnium, vitamines B2, B9 et vitamines D3 et E naturelles, qui viennent complter la formule
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
US$ 25.63
US$ 26.75
US$ 28.11
